Indication
Rifampicin-resistant Tuberculosis
2 clinical trials
13 products
Clinical trial
A Multicenter, Randomized, Double-blind, Positive Control Study to Evaluate the Efficacy and Safety of Sudapyridine (WX-081) Tables in Patients With Rifampicin-resistant Pulmonary TuberculosisStatus: , Estimated PCD: 2025-01-22
Product
BedaquilineProduct
SudapyridineClinical trial
A Multicenter, Randomized, Open-Label Study To Evaluate The Efficacy And Safety Of A Contezolid, Delamanid and Bedaquiline-Containing Short Regimen For The Treatment Of Rifampicin-Resistant Pulmonary TuberculosisStatus: Recruiting, Estimated PCD: 2026-10-01
Product
DelamanidProduct
ContezolidProduct
LevofloxacinProduct
MoxifloxacinProduct
ClofazimineProduct
LinezolidProduct
CycloserineProduct
ProthionamideProduct
PyrazinamideProduct
Para-Aminosalicylic AcidProduct
Ethambutol